Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association. 2018

Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
The Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892, USA.

HIV-1 Rev protein mediates nuclear export of unspliced and partially spliced viral RNAs for production of viral genomes and structural proteins. Rev assembles on a 351-nt Rev response element (RRE) within viral transcripts and recruits host export machinery. Small (<40-nt) RNA aptamers that compete with the RRE for Rev binding inhibit HIV-1 viral replication. We determined the X-ray crystal structure of a potential anti-HIV-1 aptamer that binds Rev with high affinity (Kd = 5.9 nM). The aptamer is structurally similar to the RRE high-affinity site but forms additional contacts with Rev unique to its sequence. Exposed bases of the aptamer interleave with the guanidinium groups of two arginines of Rev, forming stacking interactions and hydrogen bonds. The aptamer also obstructs an oligomerization interface of Rev, blocking Rev self-assembly. We propose that this aptamer can inhibit HIV-1 replication by interfering with Rev-RRE, Rev-Rev, and possibly Rev-host protein interactions.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D052157 Aptamers, Nucleotide Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity. DNA Aptamer,DNA Aptamers,RNA Aptamers,Rna Aptamer,Nucleotide Aptamers,Oligonucleotide Ligands, DNA,Oligonucleotide Ligands, RNA,Aptamer, DNA,Aptamer, Rna,Aptamers, DNA,Aptamers, RNA,DNA Oligonucleotide Ligands,RNA Oligonucleotide Ligands
D054321 rev Gene Products, Human Immunodeficiency Virus Proteins encoded by the REV GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV rev Gene Product,Trans-Activator Protein, HIV,art-trs Gene Protein, HIV,trs-art Gene Protein, HIV,HIV art-trs Gene Protein,HIV trs-art Gene Protein,Transactivator Protein, HIV,HIV Trans-Activator Protein,HIV Transactivator Protein,HIV art trs Gene Protein,HIV trs art Gene Protein,Trans Activator Protein, HIV,art trs Gene Protein, HIV,trs art Gene Protein, HIV
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
October 2015, Biochemistry,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
December 1994, Biochemistry,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
May 2001, Bioorganic & medicinal chemistry letters,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
September 1993, Cell,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
September 1996, Science (New York, N.Y.),
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
August 2013, Biophysical journal,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
August 2018, Journal of structural biology,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
September 2008, Antimicrobial agents and chemotherapy,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
February 2000, Bioorganic & medicinal chemistry letters,
Altaira D Dearborn, and Elif Eren, and Norman R Watts, and Ira W Palmer, and Joshua D Kaufman, and Alasdair C Steven, and Paul T Wingfield
October 1996, Biochemistry,
Copied contents to your clipboard!